Virax Biolabs
VRAX
VRAX
5 hedge funds and large institutions have $424K invested in Virax Biolabs in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$282K |
2 |
2
Squarepoint
New York
|
$78.8K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$39.8K |
4 |
4
Jane Street
New York
|
$22.6K |
5 |
HT
5
Headlands Technologies
Chicago,
Illinois
|
$359 |